TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of primary efficacy outcome
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in total lesion count of > 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean duration of exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Likelihood of fall prevention activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Earlier placement of DNR orders
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of avoiding hospital death
Endpoint domain: Mortality/survival
Primary endpoint: SLE Responder Index rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angiotensinogen plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: force production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BCNC width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IAC diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall health care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HBV DNA loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MELD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering serum IL-6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ingestion of alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain interference with enjoyment of life and activities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patients' diminished ability to function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Credibility of information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trustworthiness of experts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived accommodation to the audience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: success rate of IVF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life of patients undergoing IVF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sleep Efficiency (SE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Wake After Sleep Onset (WASO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Baseline viral load (VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Connectivity of the ventral striatum with the dorsal striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of addiction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone turnover markers concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal decrease of temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to become apyrexial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse drug reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Leucocytes decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: colour intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pterygium morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in FRS after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-density lipoprotein cholesterol increase after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VT (Vitality)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4(+) and CD8(+) T cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine expression patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean red cell methylated mercaptopurine metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average TGNs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: year of life saved
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of death-and/or-NEC
Endpoint domain: Mortality/survival
Primary endpoint: Mean 24 h intravenous tramadol consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Drug release percentage after 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASP (Pulmonary Artery Systolic Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MPAP (Mean Pulmonary Artery Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Documentation of contraception use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Provision of family planning services
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Leg pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of circulating CD34+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum nitrate and nitrite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total severity of symptoms after MSG ingestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average severity of symptoms after MSG ingestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of specific symptoms (headache, muscle tightness, numbness/tingling, general weakness, flushing) after MSG ingestion
Endpoint domain: Adverse events/effects
Primary endpoint: susceptibility to influenza
Endpoint domain: Mortality/survival
Primary endpoint: death from respiratory illness
Endpoint domain: Mortality/survival
Primary endpoint: mean MASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral oxygenation (rcO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased risk for overall CP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Increased risk for quadriparetic CP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Increased risk for hemiparetic CP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: sVCAM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: LVESV index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reversible defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stimulated whole saliva flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: raw scores on the PDMS‐2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total motor quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive scale of the BSID‐III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective response or nonprogression after induction GIP
Endpoint domain: Mortality/survival
Primary endpoint: Postrandomisation survival
Endpoint domain: Mortality/survival
Primary endpoint: urodynamic measurements improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychopathological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Constant-Murley score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: VAS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Breastfeeding rates at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of breastfeeding goals
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time to return of spontaneous breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microtensile Bond Strength (muTBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of meloxicam to movatec
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality in HIV positive children
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in ISK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate to medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial chylomicrons-TG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GNGf (gluconeogenesis factor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Persistence in treatment regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with treatment regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BK viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Survival rates at 1 and 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Rate of remission with CS therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CS-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Screening mammography rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean volume of water increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IPV perpetration
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients maintaining target analgesia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breast pain and tenderness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breast sizes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of insulin resistance syndrome (IRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of upper gastrointestinal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: subjective anxiety response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alprazolam clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in transverse arch widths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of throws
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postexercise plasma lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children completely cured by day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children who escaped prolonged disease and complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with care at 2-week follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physician-perceived difficulty of the encounter
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unmet expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: retention in the community treatment program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: recovery of acute ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence of infections, metastases, and death
Endpoint domain: Mortality/survival
Primary endpoint: Interobserver variation for scaphoid fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraobserver variation for scaphoid fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective clinical symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause death/cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: Arrhythmic death/cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: Circulating TMAO concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in CT ordering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum estradiol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Follicular development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good response at primary tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good response at lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ventrostriatal activation during retrieval of word pairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of change in serum albumin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Six-min walk test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-intensity interval training power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily UFV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central retinal artery pulsatility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximum change in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dietary pattern adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epidural analgesia requests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of gene mutation detection from fecal DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of gene mutation detection from fecal DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent days of abstinence from alcohol-tobacco co-use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At-risk for Auditory Processing Disorder (APD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive moods
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Negative moods
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of reporting > or =2 falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of trk C immunoreactive neurones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hours/day spent in light intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of parishes offering cancer control activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in DMT scores between trained and untrained groups
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Enrollment rate of eligible infants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Nasal trauma severity
Endpoint domain: Adverse events/effects
Primary endpoint: levels of craving for alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year FFS rates
Endpoint domain: Mortality/survival
Primary endpoint: ED(50) of bupivacaine 0.5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak progesterone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum E2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hot flush frequency and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beta carboxyl-terminal type 1 collagen telopeptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone resorption outcomes
Primary endpoint: Erectile function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: AMS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2 at anaerobic threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Probability of adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Independence in basic activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to walk up and down stairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for therapist assistance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for ephedrine to stabilize blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hypotension duration and magnitude in patients over 85
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Operation and instrumentation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-operative fracture reduction quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Log(noggin) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total exposure of ER naproxen sodium compared to IR naproxen sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak naproxen concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eyelash reflex time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for area of retinal thickening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for area of retinal hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation for area of fluorescein leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postdischarge mortality
Endpoint domain: Mortality/survival
Primary endpoint: ambulatory care visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lipid pattern change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC of MDS‐UPDRS III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AIMS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inadvertent extubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Success rate of first puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SpO2 at T1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-4- and IL-13-producing cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: allergen-specific IgG4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: specific IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total USSQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decision self-efficacy ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intervention costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean willingness-to-pay
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Understanding of risk/benefit information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: hours slept
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: hours spent in the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Spike-related activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Size of type IIa muscle fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of type IIx muscle fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary diffusion areas for IIa and IIx fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes